Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China flag China · Delayed Price · Currency is CNY
35.38
+0.03 (0.08%)
Feb 4, 2026, 3:04 PM CST

SHE:002864 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,1651,1691,102823.44419.3382
Cash & Short-Term Investments
1,1651,1691,102823.44419.3382
Cash Growth
0.04%6.11%33.83%96.38%9.77%7.66%
Accounts Receivable
547.09494.59476.42538.41446.38402.75
Other Receivables
2.612.123.072.132.554.4
Receivables
549.7496.71479.49540.54448.93407.15
Inventory
117.9995.5877.6394.6366.7766.39
Other Current Assets
44.569.8618.6723.3321.457.87
Total Current Assets
1,8771,7721,6781,482956.45863.41
Property, Plant & Equipment
436.84438.21371.7353.74275.04197.4
Long-Term Investments
10.0410.219.719.89--
Other Intangible Assets
50.551.3552.7654.956.3357.77
Long-Term Deferred Tax Assets
9.544.897.2216.6320.216.44
Long-Term Deferred Charges
10.23.122.871.310.020.09
Other Long-Term Assets
7.030.712.9612.3622.1327.43
Total Assets
2,4012,2802,1251,9311,3301,163
Accounts Payable
144.37107.9291.43121.6766.0158.81
Accrued Expenses
9.29187.96181.38215.43176.72151.54
Short-Term Debt
5050100150.4687.248.24
Current Portion of Long-Term Debt
98.881-247.6213-
Current Portion of Leases
-0.310.391.412.03-
Current Income Taxes Payable
27.098.669.1114.7317.2115.91
Current Unearned Revenue
3.983.685.5313.264.72.41
Other Current Liabilities
270.3786.5992.57138.1170.6967.26
Total Current Liabilities
603.98446.11480.41902.68437.55344.18
Long-Term Debt
-98.5-27.3540.3553.35
Long-Term Leases
1.932.332.110.331.32-
Long-Term Unearned Revenue
109.4195.991.2552.8341.427.53
Long-Term Deferred Tax Liabilities
----2.351.83
Total Liabilities
715.31642.84573.76983.18522.97426.89
Common Stock
106.28106.28106.2886.7186.6786.67
Additional Paid-In Capital
817.49816.64817.78259.43271.67271.3
Retained Earnings
785.26737.25640.06548.96463.19382.85
Treasury Stock
-25.08-24.95-15.07-15.07-30.15-20.05
Comprehensive Income & Other
---49.62--
Total Common Equity
1,6841,6351,549929.65791.38720.78
Minority Interest
1.761.972.2117.9515.8214.89
Shareholders' Equity
1,6861,6371,551947.6807.21735.66
Total Liabilities & Equity
2,4012,2802,1251,9311,3301,163
Total Debt
150.81152.14102.49427.16143.9101.59
Net Cash (Debt)
1,0141,017999.52396.28275.41280.41
Net Cash Growth
0.17%1.77%152.22%43.89%-1.78%-20.97%
Net Cash Per Share
9.679.7310.234.583.223.26
Filing Date Shares Outstanding
105.96105.91105.1595.885.5485.95
Total Common Shares Outstanding
105.96105.91105.1585.5985.5485.95
Working Capital
1,2731,3251,197579.27518.89519.23
Book Value Per Share
15.8915.4414.7310.869.258.39
Tangible Book Value
1,6331,5841,496874.75735.05663.01
Tangible Book Value Per Share
15.4214.9614.2310.228.597.71
Buildings
-398.37331.9329.36152.82143.01
Machinery
-144.4134.72125.4160.3851.53
Construction In Progress
-56.0529.313.85152.1884.23
Source: S&P Global Market Intelligence. Standard template. Financial Sources.